SOPHiA GENETICS SA (SOPH) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
SOPHiA GENETICS SA (SOPH) Bundle
Evaluate the financial outlook of SOPHiA GENETICS SA (SOPH) like an expert! This (SOPH) DCF Calculator provides pre-filled financial data and offers full flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your projections.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 25.4 | 28.4 | 40.5 | 47.6 | 62.4 | 78.5 | 98.7 | 124.1 | 156.1 | 196.4 |
Revenue Growth, % | 0 | 11.98 | 42.43 | 17.58 | 31.14 | 25.78 | 25.78 | 25.78 | 25.78 | 25.78 |
EBITDA | -30.7 | -38.8 | -70.8 | -82.7 | -70.7 | -78.5 | -98.7 | -124.1 | -156.1 | -196.4 |
EBITDA, % | -121.21 | -136.47 | -175.12 | -173.82 | -113.35 | -100 | -100 | -100 | -100 | -100 |
Depreciation | 1.9 | 2.4 | 3.6 | 5.6 | 8.3 | 7.8 | 9.9 | 12.4 | 15.6 | 19.6 |
Depreciation, % | 7.54 | 8.42 | 8.92 | 11.71 | 13.37 | 9.99 | 9.99 | 9.99 | 9.99 | 9.99 |
EBIT | -32.7 | -41.1 | -74.4 | -88.2 | -79.0 | -78.5 | -98.7 | -124.1 | -156.1 | -196.4 |
EBIT, % | -128.75 | -144.89 | -184.04 | -185.53 | -126.72 | -100 | -100 | -100 | -100 | -100 |
Total Cash | 18.4 | 97.3 | 265.3 | 178.6 | 123.3 | 74.2 | 93.3 | 117.3 | 147.6 | 185.6 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 9.7 | 7.9 | 7.1 | 6.6 | 15.2 | 19.1 | 24.0 | 30.2 | 38.0 | 47.8 |
Account Receivables, % | 38.27 | 27.65 | 17.53 | 13.98 | 24.38 | 24.36 | 24.36 | 24.36 | 24.36 | 24.36 |
Inventories | 3.6 | 3.4 | 5.7 | 5.2 | 6.5 | 9.7 | 12.1 | 15.3 | 19.2 | 24.2 |
Inventories, % | 14.23 | 11.92 | 14.16 | 10.84 | 10.39 | 12.31 | 12.31 | 12.31 | 12.31 | 12.31 |
Accounts Payable | 1.7 | 1.3 | 2.3 | 2.2 | 2.3 | 4.0 | 5.0 | 6.3 | 7.9 | 9.9 |
Accounts Payable, % | 6.82 | 4.51 | 5.78 | 4.56 | 3.62 | 5.06 | 5.06 | 5.06 | 5.06 | 5.06 |
Capital Expenditure | -3.0 | -3.2 | -6.7 | -10.4 | -9.2 | -12.0 | -15.1 | -19.0 | -23.8 | -30.0 |
Capital Expenditure, % | -11.96 | -11.28 | -16.49 | -21.83 | -14.79 | -15.27 | -15.27 | -15.27 | -15.27 | -15.27 |
Tax Rate, % | -0.61915 | -0.61915 | -0.61915 | -0.61915 | -0.61915 | -0.61915 | -0.61915 | -0.61915 | -0.61915 | -0.61915 |
EBITAT | -32.8 | -39.3 | -74.6 | -88.1 | -79.5 | -77.7 | -97.7 | -122.9 | -154.6 | -194.5 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -45.5 | -38.5 | -78.2 | -92.1 | -90.2 | -87.2 | -109.3 | -137.5 | -173.0 | -217.6 |
WACC, % | 8.94 | 8.92 | 8.94 | 8.94 | 8.94 | 8.93 | 8.93 | 8.93 | 8.93 | 8.93 |
PV UFCF | ||||||||||
SUM PV UFCF | -543.3 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -222 | |||||||||
Terminal Value | -3,201 | |||||||||
Present Terminal Value | -2,087 | |||||||||
Enterprise Value | -2,630 | |||||||||
Net Debt | -105 | |||||||||
Equity Value | -2,525 | |||||||||
Diluted Shares Outstanding, MM | 65 | |||||||||
Equity Value Per Share | -39.00 |
What You Will Get
- Authentic SOPHiA Data: Preloaded financial metrics – including revenue and EBIT – derived from real and projected data.
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Real-Time Valuation Updates: Automatic recalculations to assess the effects of changes on SOPHiA GENETICS’ fair value.
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and in-depth forecasts.
- Efficient and Precise: Bypass the need to create models from the ground up while ensuring accuracy and adaptability.
Key Features
- Comprehensive Genomic Data Analysis: Leverage advanced algorithms to interpret complex genomic data.
- Integrated Data Sharing Platform: Seamlessly collaborate with healthcare providers and researchers through a secure interface.
- Customizable Reporting Tools: Tailor reports to meet specific research and clinical needs.
- Real-Time Analytics: Gain insights from live data to enhance decision-making processes.
- User-Friendly Dashboard: Intuitive visualizations make it easy to track and analyze key genomic metrics.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered SOPHiA GENETICS data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for SOPHiA GENETICS' intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose SOPHiA GENETICS SA (SOPH)?
- Streamline Your Process: No need to build complex genetic analysis tools from scratch – they’re readily available.
- Enhance Precision: Access to dependable genomic data and algorithms minimizes errors in analysis.
- Completely Adaptable: Customize the tools to align with your specific research needs and objectives.
- User-Friendly Interface: Intuitive visualizations and outputs simplify the interpretation of results.
- Endorsed by Professionals: Crafted for experts who prioritize accuracy and functionality.
Who Should Use This Product?
- Genetics Students: Explore genomic data analysis techniques and apply them using real-world examples.
- Researchers: Integrate advanced genomic models into your studies or clinical trials.
- Healthcare Professionals: Validate your hypotheses and evaluate genomic outcomes for SOPHiA GENETICS SA (SOPH).
- Bioinformaticians: Enhance your analysis with a comprehensive, customizable genomic data platform.
- Pharmaceutical Companies: Understand how genomic data is utilized in the evaluation of drug efficacy and safety.
What the Template Contains
- Preloaded SOPH Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.